June 27, 2012
On Tuesday, June 26, 2012, the Senate passed a compromise five-year measure to reauthorize FDA drug and medical-device user fees for five years and to create two new user fee programs, one for generic drugs and the other for generic biologic drugs.
The Senate voted 92-4 to pass the bill which is a negotiated compromise between similar measures that separately passed in the House and Senate earlier this month. This has readied the bill for President Obama’s signature.
SNM will bring you updates as they come.